| scholarly article | Q13442814 |
| P50 | author | Ashok Kumar | Q44603002 |
| P2093 | author name string | Bryant G Darnay | |
| Yongwon Choi | |||
| Sanjay Srivastava | |||
| Shephali Bhatnagar | |||
| Pradyut K Paul | |||
| Vivek Mishra | |||
| P2860 | cites work | TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL | Q21092160 |
| Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress | Q22010800 | ||
| XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor | Q24292102 | ||
| Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response | Q24304232 | ||
| The E3 ligase TRAF6 regulates Akt ubiquitination and activation | Q24310343 | ||
| Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation | Q24321363 | ||
| Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy | Q24555065 | ||
| In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker | Q24633015 | ||
| The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL | Q24654977 | ||
| Autophagy in the Pathogenesis of Disease | Q27860558 | ||
| Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease | Q36910684 | ||
| TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta | Q37052635 | ||
| During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation | Q37264046 | ||
| Translation attenuation through eIF2alpha phosphorylation prevents oxidative stress and maintains the differentiated state in beta cells | Q37343526 | ||
| Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response | Q37389501 | ||
| Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs | Q37579634 | ||
| Autophagy in skeletal muscle | Q37687551 | ||
| Mitochondrial fission and remodelling contributes to muscle atrophy. | Q39713513 | ||
| Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice | Q39975807 | ||
| The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle | Q40056196 | ||
| TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation | Q40119268 | ||
| The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis | Q41791624 | ||
| UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. | Q42041480 | ||
| Fasting-related autophagic response in slow- and fast-twitch skeletal muscle | Q43149447 | ||
| IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. | Q44853225 | ||
| Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes | Q45000394 | ||
| Coexpression after electroporation of plasmid mixtures into muscle in vivo | Q45875859 | ||
| Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function | Q46821957 | ||
| Autophagy is required to maintain muscle mass. | Q51411361 | ||
| Signal integration in the endoplasmic reticulum unfolded protein response | Q27860577 | ||
| Mechanisms underlying ubiquitination | Q27860656 | ||
| Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase | Q27938837 | ||
| Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules | Q28248180 | ||
| TWEAK attenuates the transition from innate to adaptive immunity | Q28284920 | ||
| Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase | Q28296183 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression | Q28565720 | ||
| Expression of endoplasmic reticulum stress proteins during skeletal muscle disuse atrophy | Q28571228 | ||
| Identification of ubiquitin ligases required for skeletal muscle atrophy | Q28582211 | ||
| TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy | Q28585634 | ||
| XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks | Q28591575 | ||
| p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death | Q29547297 | ||
| FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells | Q29614482 | ||
| FoxO3 controls autophagy in skeletal muscle in vivo | Q29614483 | ||
| Ubiquitin signalling in the NF-kappaB pathway | Q29616322 | ||
| Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities | Q29617768 | ||
| The ubiquitin-proteasome pathway: on protein death and cell life | Q29619270 | ||
| Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy | Q29619282 | ||
| The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins | Q29620170 | ||
| Lysosomal proteolysis in skeletal muscle | Q33222353 | ||
| The ubiquitin-proteasome pathway and pathogenesis of human diseases | Q33540242 | ||
| PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation | Q33582021 | ||
| The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. | Q33751732 | ||
| The transcription factor ATF4 promotes skeletal myofiber atrophy during fasting | Q33780239 | ||
| TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine | Q34132318 | ||
| Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. | Q34439637 | ||
| Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3. | Q34490064 | ||
| Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression | Q34563098 | ||
| Nuclear factor-kappa B signaling in skeletal muscle atrophy. | Q34593476 | ||
| The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1α/ATF6α complex | Q34673344 | ||
| The many forks in FOXO's road | Q35079447 | ||
| Ubiquitin-protein ligases in muscle wasting | Q36241893 | ||
| Intracellular signaling during skeletal muscle atrophy | Q36288224 | ||
| ATF4-dependent transcription mediates signaling of amino acid limitation | Q36655003 | ||
| Signal integration and diversification through the p62 scaffold protein | Q36686435 | ||
| Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome | Q36749044 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1248-1259 | |
| P577 | publication date | 2012-01-30 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms | |
| P478 | volume | 32 |
| Q33849584 | An ethanolic extract of Artemisia dracunculus L. regulates gene expression of ubiquitin-proteasome system enzymes in skeletal muscle: potential role in the treatment of sarcopenic obesity |
| Q34529689 | An overview of technical considerations for Western blotting applications to physiological research. |
| Q42443337 | Autophagic flux and oxidative capacity of skeletal muscles during acute starvation |
| Q37742823 | BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice |
| Q27012762 | Cellular and molecular mechanisms of muscle atrophy |
| Q33931130 | DNA methyltransferase 3a and mitogen-activated protein kinase signaling regulate the expression of fibroblast growth factor-inducible 14 (Fn14) during denervation-induced skeletal muscle atrophy |
| Q38107334 | Deubiquitinases in skeletal muscle atrophy |
| Q37593034 | Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy. |
| Q60956528 | Do neurogenic and cancer-induced muscle atrophy follow common or divergent paths? |
| Q91808662 | ER Stress and Unfolded Protein Response in Cancer Cachexia |
| Q47295145 | ER stress in skeletal muscle remodeling and myopathies |
| Q35576497 | Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction. |
| Q39125967 | Emerging roles of ER stress and unfolded protein response pathways in skeletal muscle health and disease |
| Q57191736 | Genetic Alterations of TRAF Proteins in Human Cancers |
| Q54448263 | High- versus moderate-intensity aerobic exercise training effects on skeletal muscle of infarcted rats. |
| Q40956876 | Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia |
| Q36016910 | Loss of mitofusin 2 promotes endoplasmic reticulum stress |
| Q39726480 | Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation |
| Q41398425 | MicroRNA-351 inhibits denervation-induced muscle atrophy by targeting TRAF6 |
| Q28068034 | Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans? |
| Q38303979 | Muscle wasting in disease: molecular mechanisms and promising therapies |
| Q90238992 | MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice |
| Q37249618 | OX40 signaling favors the induction of T(H)9 cells and airway inflammation |
| Q38105829 | Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome |
| Q41170120 | Reciprocal interaction between TRAF6 and notch signaling regulates adult myofiber regeneration upon injury |
| Q28658848 | Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program. |
| Q92132429 | Requirement for p62 acetylation in the aggregation of ubiquitylated proteins under nutrient stress |
| Q38184230 | SQSTM1 mutations--bridging Paget disease of bone and ALS/FTLD. |
| Q34200869 | Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1 |
| Q34980534 | Spermine oxidase maintains basal skeletal muscle gene expression and fiber size and is strongly repressed by conditions that cause skeletal muscle atrophy. |
| Q50130561 | TAK1 regulates skeletal muscle mass and mitochondrial function |
| Q41838109 | TLR4-defective (C3H/HeJ) mice are not protected from cast immobilization-induced muscle atrophy |
| Q89581381 | TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation |
| Q36972287 | TRAF molecules in cell signaling and in human diseases |
| Q38982057 | TRAF6 inhibition rescues dexamethasone-induced muscle atrophy |
| Q43105046 | TRAF6 regulates satellite stem cell self-renewal and function during regenerative myogenesis. |
| Q89805562 | TRPC Channels in Cardiac Plasticity |
| Q91666310 | TRPC3-Nox2 axis mediates nutritional deficiency-induced cardiomyocyte atrophy |
| Q36097846 | TWEAK and TRAF6 regulate skeletal muscle atrophy. |
| Q37516544 | TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction. |
| Q64282417 | Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy |
| Q97644330 | The Effects of Cold Water Immersion and Active Recovery on Molecular Factors That Regulate Growth and Remodeling of Skeletal Muscle After Resistance Exercise |
| Q48301094 | The Role of Epigenetic Regulation and Pluripotency-Related MicroRNAs in Differentiation of Pancreatic Stem Cells to Beta Cells |
| Q41907326 | The Role of Ubiquitination in TWEAK-Stimulated Signaling |
| Q26999255 | The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease |
| Q38129961 | The TWEAK-Fn14 system as a potential drug target |
| Q92355217 | The Toll-Like Receptor/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia |
| Q39430236 | The impact of postexercise essential amino acid ingestion on the ubiquitin proteasome and autophagosomal-lysosomal systems in skeletal muscle of older men. |
| Q36974840 | The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling. |
| Q38924199 | The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation |
| Q91732402 | Two pools of IRE1α in cardiac and skeletal muscle cells |
| Q28854380 | miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation |
Search more.